openPR Logo
Press release

Influenza Vaccine Market to Exceed Valuation of US$ 7.2 Billion by 2031: TMR Study

Influenza Vaccine

Influenza Vaccine

The latest research study released by Transparency Market Research on "๐ˆ๐ง๐Ÿ๐ฅ๐ฎ๐ž๐ง๐ณ๐š ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ Forecast to 2023-2031 โ€ณ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Influenza Vaccine industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data.

Influenza Vaccine market is estimated to attain a valuation of US$ 7.2 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.2% during the forecast period, 2023-2031

๐†๐ž๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=211

The global influenza vaccine market is expected to grow at a rapid pace in the next few years. This can be ascribed to surge in prevalence of flu, rise in awareness, increase in geriatric population, and government initiatives to promote vaccination. Surge in number of collaborations between market players and governments to ensure availability of flu vaccines, such as swine flu vaccine, in remote areas is expected accelerate market development.

Introduction of new vaccines and increase in adoption in developing and underdeveloped countries offer significant opportunities to market players. Key players are focusing on research and development of innovative influenza vaccines. However, volatility in prices of raw materials used in the manufacture of vaccines, high cost of flu vaccines, and limited awareness and access in developing countries are expected to hamper market progress.

๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐•๐ž๐ซ๐ฌ๐ข๐จ๐ง ๐จ๐Ÿ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ:

Detailed industry forecast
Brief Introduction to the research report.
Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐›๐ž๐Ÿ๐จ๐ซ๐ž ๐ฉ๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=211

๐Š๐ž๐ฒ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ

In February 2021, Pfizer and BioNTech announced the approval of COVID-19 vaccine for emergency use in the U.S. This approval marked a major milestone in the global fight against COVID-19, and demonstrated the ability of pharmaceutical companies to quickly develop and bring to market vaccines for emerging infectious diseases.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

Pfizer, Inc., Sanofi, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Inc., Novartis AG, Roche Holding AG, Seqirus (CSL Limited), Johnson & Johnson, and Daiichi Sankyo Company, Limited

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง -

๐“๐ฒ๐ฉ๐ž

Inactivated
Live Attenuated

๐•๐š๐ฅ๐ž๐ง๐œ๐ฒ

Quadrivalent
Trivalent

๐€๐ ๐ž ๐†๐ซ๐จ๐ฎ๐ฉ

Pediatric
Adult

๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ

Hospitals & Pharmacies
Government & Institutional Supply
Others

๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฅ๐ž๐ญ๐ฌ ๐ฒ๐จ๐ฎ ๐ข๐๐ž๐ง๐ญ๐ข๐Ÿ๐ฒ ๐ญ๐ก๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ˆ๐ง๐Ÿ๐ฅ๐ฎ๐ž๐ง๐ณ๐š ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐›๐ฒ ๐ฆ๐ž๐š๐ง๐ฌ ๐จ๐Ÿ ๐š ๐ซ๐ž๐ ๐ข๐จ๐ง:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

๐‡๐š๐ฏ๐ž ๐€๐ง๐ฒ ๐๐ฎ๐ž๐ซ๐ฒ? ๐€๐ฌ๐ค ๐“๐จ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=211

๐Š๐ž๐ฒ ๐…๐ž๐š๐ญ๐ฎ๐ซ๐ž๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ˆ๐ง๐Ÿ๐ฅ๐ฎ๐ž๐ง๐ณ๐š ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: -

โžค Analyze competitive developments such as expansions, deployments, new product launches, and market acquisitions.

โžค Examine the market opportunities for stakeholders by identifying higher growth sections.

โžค To study and analyze the global Influenza Vaccine industry status and forecast including key regions.

โžค An in-depth analysis of key product segments and application spectrum, providing strategic recommendations to incumbents and new entrants to give them a competitive advantage over others.

โžค It provides a comprehensive analysis of key regions of the industry as well as a SWOT analysis and Porter's Five Forces analysis to provide a deeper understanding of the market.

โžค It helps you make strategic business decisions and investment plans.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก -

๐‹๐ข๐ช๐ฎ๐ข๐ ๐…๐ข๐ฅ๐ฅ๐ž๐ ๐‡๐š๐ซ๐ ๐‚๐š๐ฉ๐ฌ๐ฎ๐ฅ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2022/06/15/2463113/0/en/Liquid-Filled-Hard-Capsules-Market-to-Exceed-Valuation-of-US-4-Bn-by-2031-TMR-Study.html

๐๐š๐ฉ๐ž๐ซ๐›๐จ๐š๐ซ๐ ๐๐š๐œ๐ค๐š๐ ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2022/06/15/2463279/0/en/Paperboard-Packaging-Market-to-Reach-299-4-Million-by-2031-TMR-Study.html

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Vaccine Market to Exceed Valuation of US$ 7.2 Billion by 2031: TMR Study here

News-ID: 3331524 • Views: โ€ฆ

More Releases from Transparency Market Research

Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion by 2036, Driven by Rising Opioid Use and Targeted Therapies
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion โ€ฆ
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronicโ€ฆ
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product Type / By Impact Frequency | China โ€ข India โ€ข Japan โ€ข U.S.
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T โ€ฆ
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compoundโ€ฆ
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Billion in 2025 to US$ 244.4 Billion at 27% CAGR
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil โ€ฆ
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036. This growth trajectory reflects the transition of automobiles from mechanically driven products toโ€ฆ
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable Drug Demand
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable โ€ฆ
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,โ€ฆ

All 5 Releases


More Releases for Influenza

Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies โ€ฆ
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.โ€ฆ
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza โ€ฆ
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780 This latest report researches the industry structure, sales, revenue,โ€ฆ
Influenza Medication Market - Fight off the influenza virus with effective and r โ€ฆ
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859 This latest report researches the industry structure, sales, revenue,โ€ฆ
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced โ€ฆ
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, whichโ€ฆ
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating โ€ฆ
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, whichโ€ฆ
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del โ€ฆ
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,โ€ฆ